SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-008190
Filing Date
2023-05-05
Accepted
2023-05-05 07:16:07
Documents
15
Period of Report
2023-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K edit-20230505x8k.htm   iXBRL 8-K 34805
2 EX-99.1 edit-20230505xex99d1.htm EX-99.1 66669
3 GRAPHIC edit-20230505xex99d1001.jpg GRAPHIC 6224
  Complete submission text file 0001558370-23-008190.txt   324668

Data Files

Seq Description Document Type Size
4 EX-101.SCH edit-20230505.xsd EX-101.SCH 3266
5 EX-101.LAB edit-20230505_lab.xml EX-101.LAB 630
6 EX-101.PRE edit-20230505_pre.xml EX-101.PRE 10175
9 EXTRACTED XBRL INSTANCE DOCUMENT edit-20230505x8k_htm.xml XML 4626
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37687 | Film No.: 23891219
SIC: 2836 Biological Products, (No Diagnostic Substances)